Veeva Systems Inc. (NYSE:VEEV – Get Free Report) insider Thomas Schwenger sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $231.43, for a total transaction of $231,430.00. Following the transaction, the insider owned 23,204 shares in the company, valued at $5,370,101.72. The trade was a 4.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
Veeva Systems Price Performance
Shares of Veeva Systems stock opened at $222.25 on Friday. The firm has a 50 day simple moving average of $240.03 and a 200 day simple moving average of $268.98. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50. The firm has a market cap of $36.53 billion, a P/E ratio of 43.24, a P/E/G ratio of 1.64 and a beta of 1.07.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 EPS for the quarter, beating analysts’ consensus estimates of $1.95 by $0.09. The firm had revenue of $0.81 million for the quarter, compared to analyst estimates of $792.37 million. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The business’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same period last year, the company earned $1.75 EPS. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. On average, sell-side analysts expect that Veeva Systems Inc. will post 4.35 EPS for the current year.
Analysts Set New Price Targets
Several equities research analysts have recently commented on VEEV shares. UBS Group lowered their price target on shares of Veeva Systems from $310.00 to $280.00 and set a “neutral” rating for the company in a research report on Friday, November 21st. Jefferies Financial Group reaffirmed a “buy” rating and set a $330.00 target price on shares of Veeva Systems in a report on Monday, November 24th. William Blair reissued an “outperform” rating on shares of Veeva Systems in a research note on Friday, October 17th. Robert W. Baird lifted their price objective on Veeva Systems from $314.00 to $319.00 and gave the stock an “outperform” rating in a research note on Friday, November 21st. Finally, TD Cowen upgraded Veeva Systems from a “hold” rating to a “buy” rating and upped their price objective for the company from $297.00 to $380.00 in a report on Tuesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus target price of $308.04.
View Our Latest Stock Analysis on VEEV
Hedge Funds Weigh In On Veeva Systems
Several institutional investors have recently modified their holdings of VEEV. GPS Wealth Strategies Group LLC raised its holdings in Veeva Systems by 196.4% during the 3rd quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock worth $25,000 after buying an additional 55 shares during the period. Board of the Pension Protection Fund bought a new stake in shares of Veeva Systems during the fourth quarter worth $27,000. Raiffeisen Bank International AG acquired a new stake in shares of Veeva Systems during the third quarter worth $28,000. Trust Co. of Toledo NA OH bought a new stake in Veeva Systems in the 2nd quarter valued at $29,000. Finally, OLD Second National Bank of Aurora bought a new stake in Veeva Systems in the 3rd quarter valued at $30,000. Institutional investors own 88.20% of the company’s stock.
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Further Reading
- Five stocks we like better than Veeva Systems
- Wall Street Alert: Buy AES
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
